Aurora Financial JournalRecordati Industria Chimica E Farmaceutica S.p.A. In Breve Recordati S.p.A. (REC.MI)
Euronext Milan · Financial statements, TTM figures and earnings dates
In fiscal year 2021 (ended December 31, 2021), Recordati Industria Chimica E Farmaceutica S.p.A. In Breve Recordati S.p.A. reported revenue of €1.58B and net income of €386.0M. Annual financial statements are available for fiscal years 2020 to 2021, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| EUR | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | €1.58B | €1.45B |
| Gross profit | €1.15B | €1.04B |
| Operating income | €490.2M | €469.0M |
| Net income | €386.0M | €355.0M |
| Cash flow | ||
| Operating cash flow | €491.6M | €403.6M |
| Capital expenditure | €21.9M | €21.3M |
| Free cash flow | €469.8M | €382.3M |
| Balance sheet | ||
| Cash and equivalents | €244.6M | €188.2M |
| Total assets | €2.82B | €2.71B |
| Total liabilities | €1.43B | €1.44B |
| Shareholders' equity | €1.38B | €1.28B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in EUR as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full REC.MI page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open REC.MI financials →